XML 35 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Instruments
6 Months Ended
Jun. 30, 2012
Financial Instruments [Abstract]  
Financial Instruments
6.
Financial Instruments

The Company's material financial instruments include cash and cash equivalents and investments classified as available for sale; investments classified as available for sale are the only assets or liabilities that are measured at fair value on a recurring basis.  All of the Company's investments mature in one year or less.  The par value, amortized cost, gross unrealized gains and losses and estimated fair value of investments classified as available for sale as of June 30, 2012 and December 31, 2011 are as follows (in thousands):


                           
Fair Value Measurements Using
       
                           
Quoted Prices in
Active Markets
   
Significant
Other
       
   
Par
   
Amortized
   
Gross
Unrealized
   
Gross
Unrealized
   
for
Identical Assets
   
Observable
Inputs
   
Total
Fair Value
 
   
Value
   
Cost
   
Gains
   
Losses
   
(Level 1)
   
(Level 2)
   
Measurements
 
                                           
 June 30, 2012
                                         
  U.S. Treasury securities
  $ 37,300     $ 37,288     $ 2     $ -     $ 37,290     $ -     $ 37,290  
                                                         
 December 31, 2011
                                                       
  U.S. Treasury securities
  $ 43,300     $ 43,296     $ 1     $ -     $ 43,297     $ -     $ 43,297  



As of June 30, 2012, the Company did not have any assets or liabilities measured at fair value on a nonrecurring basis.  As more fully discussed in the 2011 10-K, during the fourth quarter of 2010 the Company recorded an impairment charge for certain real estate assets at the San Elijo Hills Towncenter ("Towncenter") which reduced the carrying amount of those assets to their fair value of $1,200,000 at December 31, 2010.

For cash and cash equivalents, the carrying amounts of such financial instruments approximate their fair values.

The Company does not invest in any derivatives or engage in any hedging activities.